Navigation Links
Custom Splice Arrays from ExonHit Therapeutics Inc.

ProductsCustom Splice Arrays from ExonHit Therapeutics Inc.
Company ExonHit Therapeutics Inc.
Item Custom Splice Arrays
Price Inquire
Description Through its SpliceArray service, ExonHit can design custom microarrays to detect alternative splicing events starting with your gene list. Proprietary algorithms are used to identify splice events and design microarray probes from high quality, spliced cDNAs aligned to the human genome. Each splice event contained in a custom SpliceArray is profiled with a patent protected combination of six exon and junction probes that allows robust, specific detection of the two possible molecular species resulting from each splice event. Custom SpliceArrays are produced on the Agilent platform.
Info ExonHit Therapeutics Inc.ExonHit Therapeutics Inc.
Avenel Business Park
217 Perry Parkway
Gaithersburg, MD 20877

Customer Service: 240-683-7050
Fax Number: 240-683-7060
Web Site: http://www.exonhit.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Peptide Design and Custom Synthesis from Global Peptide Services, LLC.
2. Custom Arraying Service from Whatman, Inc
3. Custom 2-OMe RNA Aptamer Microarray from LC Sciences
4. Custom DNA Aptamer Microarray from LC Sciences
5. Custom 2-F RNA Aptamer Microarray from LC Sciences
6. Custom Peptide Microarray - Comprehensive Service from LC Sciences
7. Custom DNA Microarray from LC Sciences
8. Custom Antibody Production Services from Aves Labs, Inc.
9. EvoQuest ™ Custom Laboratory Services from Invitrogen
10. Custom Processing Service from Whatman, Inc
11. Custom Phosphopeptide Microarray from LC Sciences
...sue microarrays are derived from Paraffin embedded...ality control procedures to ensure the highest qua... in one block, sectioned at a thickness of 5 micro...e (3-5 mm in diameter) in comparison to core secti...
...standards consist of seven reduced, denatured prot... bovine carbonic anhydrase, rabbit muscle GAPDH, b...min) with pIs ranging from 4.5 to 8.5 and molecula... standards provide calibrated references for the p...
PROTEAN II xi Multi-Cell 2-D Conversion Kit from Bio-Rad
Printer Paper for Model 680 Series Readers, 2 rolls from Bio-Rad
Biology Products:
(Date:11/30/2009)...n University researchers Ron Falta and Larry Murdo...ion Agency grant to study the safe storage of carb...elow the earth,s surface. , With carbon dioxide ... the leading cause of global warming, geologic sto...natives for reducing emissions using current techn...
(Date:11/30/2009)... 2009) Scientists and engineers from two of the n...ill come together Dec. 7 with leading academicians...g blood. , Much like moving oil through a pipeli...oth systems need clean, well-functioning pipes (or...o function efficiently. Both industries also are c...
(Date:11/30/2009)... lower early bird registration rates and register ...of 2010 at http://www.iofwco-ecceo10.org/ , W...ternational Osteoporosis Foundation (IOF) and the ... of Osteoporosis and Osteoarthritis (ESCEO). More ...expected to attend. The exciting scientific progra...
Breaking Biology News(10 mins):Similarities of pumping blood and oil examined 2Similarities of pumping blood and oil examined 3Inc Magazine Unveils Exclusive List of Americas Fastest Growing Private Companies the Inc 5000 54364 1Inc Magazine Unveils Exclusive List of Americas Fastest Growing Private Companies the Inc 5000 54364 2Inc Magazine Unveils Exclusive List of Americas Fastest Growing Private Companies the Inc 5000 54364 3Sisters of Charity Health System Welcomes Shannon Fogarty Jerse as Deputy General Counsel 54361 1Sisters of Charity Health System Welcomes Shannon Fogarty Jerse as Deputy General Counsel 54361 2Sisters of Charity Health System Welcomes Shannon Fogarty Jerse as Deputy General Counsel 54361 3When It Comes to Casual Sex Men Arent So Picky 54358 1When It Comes to Casual Sex Men Arent So Picky 54358 2
...w anti-viral drug designated FV-100, which could a...herpes zoster or shingles, has entered the second ...ed and patented by scientists based at Cardiff Uni... recently been initiated in America. Previous res...more potent than existing treatments in early lab ...
...ns of Duchenne Muscular Dystrophy (DMD) for 2 yea...ific treatment, about the same length of delay chi...dvances in genetic testing and treatment. A simple...oms and signs of motor delays and abnormalities co...wborn screening are conducted. , Recent Universit...
...ool of Tropical Medicine (LSTM) has been awarded a...h to lead a five year project to develop a Field A...stance to public health insecticides in mosquitoes...ria in sub-Saharan Africa are the use of insectici...ying (IRS) of insecticides. Scientists at LSTM, t...
Other Biology News:Clinical trials for shingles drug take an important step forward 2Muscular dystrophy diagnosis delayed almost 2.5 years in boys 2$1.6 million grant to lead development of resistance-detecting field kit 2
(Date:11/30/2009)..., , AMSTERDAM, November 30 /PRNewswi...ounces today that the first patients have been enr...rial with ATIR(TM). The study is,designed to show ...ter one,year following an allogeneic stem cell tra...onor in blood cancer patients eligible for an allo...
(Date:11/30/2009)..., , CHANGCHUN, China and LOS ANGEL...ongxin Pharmaceuticals, Inc. (OTC Bulletin Board: ...any,), a leading manufacturer, distributor and,ret...day announced it has,completed preparation for dis... , The Chinese government recently formal...
(Date:11/30/2009)..., , NOVATO, Calif., Nov. 30 /PRNewswire-Fi... BMRN ) announced today that the Food and Drug Adm...ion for 3,4-diaminopyridine (3,4-DAP), amifampridi...ert Eaton Myasthenic Syndrome (LEMS). 3,4-DAP has...e E.U. Also, in October 2009, the Committee for M...
(Date:11/30/2009)..., , SEATTLE, Nov. 30 /PRNewswire-Fi...and MTA: CTIC) announced today that its new class ...-platinates, demonstrated a stronger anti-tumor po... platinum-based compounds as well as the ability t...es. The results were presented in a paper titled ...
Breaking Biology Technology:Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3